Neogen Corporation Operating Cash Flow
Neogen Corporation (NEOG) reported Operating Cash Flow of $83.20 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- Neogen Corporation net cash provided by (used in) operating activities for the quarter ending 2026-05-31 was $30.20M, a 84.15% increase year-over-year.
- Neogen Corporation net cash provided by (used in) operating activities for the quarter ending 2026-02-28 was $22.70M, a 16.66% increase year-over-year.
- Neogen Corporation net cash provided by (used in) operating activities for the quarter ending 2025-11-30 was $19.44M, a 51.70% decline year-over-year.
- Neogen Corporation net cash provided by (used in) operating activities for the quarter ending 2025-08-31 was $10.85M.
- Neogen Corporation net cash provided by (used in) operating activities for fiscal 2026 was $83.20M, a 42.96% increase from fiscal 2025.
- Neogen Corporation net cash provided by (used in) operating activities for fiscal 2025 was $58.20M, a 64.87% increase from fiscal 2024.
- Neogen Corporation net cash provided by (used in) operating activities for fiscal 2024 was $35.30M, a 13.96% decline from fiscal 2023.
- Neogen Corporation net cash provided by (used in) operating activities for fiscal 2023 was $41.03M, a 39.70% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | $30.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $52.90M derived: sum of 2 quarters · filed 2026-07-30 | $72.35M derived: sum of 3 quarters · filed 2026-07-30 | $83.20M 10-K · filed 2026-07-30 | ||
| 2026-02-28 | $22.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $42.15M derived: sum of 2 quarters · filed 2026-04-09 | $53.00M 10-Q · filed 2026-04-09 | $69.40M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | $19.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $30.30M 10-Q · filed 2026-01-08 | $46.70M derived: sum of 3 quarters · filed 2026-07-30 | $66.16M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | $10.85M 10-Q · filed 2025-10-09 | $27.25M derived: sum of 2 quarters · filed 2026-07-30 | $46.71M derived: sum of 3 quarters · filed 2026-07-30 | $86.97M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | $16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $35.86M derived: sum of 2 quarters · filed 2026-07-30 | $76.11M derived: sum of 3 quarters · filed 2026-07-30 | $58.20M 10-K · filed 2026-07-30 | $58.24M 10-K · filed 2025-07-30 | |
| 2025-02-28 | $19.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $59.71M derived: sum of 2 quarters · filed 2026-04-09 | $41.80M 10-Q · filed 2026-04-09 | $41.70M 10-Q · filed 2025-04-09 | $68.58M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | $40.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $22.34M 10-Q · filed 2026-01-08 | $49.12M derived: sum of 3 quarters · filed 2026-07-30 | $18.92M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | -$17.91M 10-Q · filed 2025-10-09 | $8.87M derived: sum of 2 quarters · filed 2026-07-30 | -$21.34M derived: sum of 3 quarters · filed 2026-07-30 | -$5.62M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-05-31 | $26.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$3.42M derived: sum of 2 quarters · filed 2026-07-30 | $12.29M derived: sum of 3 quarters · filed 2026-07-30 | $35.30M 10-K · filed 2026-07-30 | $35.26M 10-K · filed 2024-07-30 | |
| 2024-02-29 | -$30.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | -$14.49M derived: sum of 2 quarters · filed 2025-04-09 | $8.52M 10-Q · filed 2025-04-09 | $99.48M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-11-30 | $15.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | $38.72M 10-Q · filed 2025-01-15 | $129.69M derived: sum of 3 quarters · filed 2025-07-30 | $112.62M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-08-31 | $23.01M 10-Q · filed 2024-10-10 | $113.97M derived: sum of 2 quarters · filed 2025-07-30 | $96.91M derived: sum of 3 quarters · filed 2025-07-30 | $78.18M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-05-31 | $90.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $73.90M derived: sum of 2 quarters · filed 2025-07-30 | $55.17M derived: sum of 3 quarters · filed 2025-07-30 | $41.03M 10-K · filed 2025-07-30 | ||
| 2023-02-28 | -$17.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$35.80M derived: sum of 2 quarters · filed 2024-04-09 | -$49.94M 10-Q · filed 2024-04-09 | -$29.55M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-11-30 | -$18.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$32.87M 10-Q · filed 2024-01-09 | -$12.48M derived: sum of 3 quarters · filed 2024-07-30 | -$5.89M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-08-31 | -$14.14M 10-Q · filed 2023-10-10 | $6.25M derived: sum of 2 quarters · filed 2024-07-30 | $12.84M derived: sum of 3 quarters · filed 2024-07-30 | $30.68M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-05-31 | $20.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $26.98M derived: sum of 2 quarters · filed 2024-07-30 | $44.83M derived: sum of 3 quarters · filed 2024-07-30 | $68.04M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | $6.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | $24.44M derived: sum of 2 quarters · filed 2023-04-04 | $47.65M 10-Q · filed 2023-04-04 | $69.62M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-11-30 | $17.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $41.06M 10-Q · filed 2023-01-09 | $63.03M derived: sum of 3 quarters · filed 2023-08-15 | $74.62M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-08-31 | $23.21M 10-Q · filed 2022-09-30 | $45.18M derived: sum of 2 quarters · filed 2023-08-15 | $56.77M derived: sum of 3 quarters · filed 2023-08-15 | $79.17M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-05-31 | $21.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $33.56M derived: sum of 2 quarters · filed 2023-08-15 | $55.95M derived: sum of 3 quarters · filed 2023-08-15 | $81.09M 10-K · filed 2023-08-15 | ||
| 2021-02-28 | $11.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | $33.99M derived: sum of 2 quarters · filed 2022-04-01 | $59.12M 10-Q · filed 2022-04-01 | $84.75M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-11-30 | $22.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | $47.52M 10-Q · filed 2021-12-30 | $73.15M derived: sum of 3 quarters · filed 2022-07-27 | $92.93M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-08-31 | $25.13M 10-Q · filed 2021-09-30 | $50.76M derived: sum of 2 quarters · filed 2022-07-27 | $70.54M derived: sum of 3 quarters · filed 2022-07-27 | $87.29M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-05-31 | $25.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $45.41M derived: sum of 2 quarters · filed 2022-07-27 | $62.16M derived: sum of 3 quarters · filed 2022-07-27 | $85.88M 10-K · filed 2022-07-27 | ||
| 2020-02-29 | $19.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $36.53M derived: sum of 2 quarters · filed 2021-03-31 | $60.25M 10-Q · filed 2021-03-31 | $81.13M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-11-30 | $16.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $40.47M 10-Q · filed 2020-12-29 | $61.35M derived: sum of 3 quarters · filed 2021-07-30 | $71.73M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-08-31 | $23.72M 10-Q · filed 2020-09-30 | $44.60M derived: sum of 2 quarters · filed 2021-07-30 | $54.98M derived: sum of 3 quarters · filed 2021-07-30 | $71.48M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-05-31 | $20.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $31.26M derived: sum of 2 quarters · filed 2021-07-30 | $47.76M derived: sum of 3 quarters · filed 2021-07-30 | $63.84M 10-K · filed 2021-07-30 | ||
| 2019-02-28 | $10.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $26.88M derived: sum of 2 quarters · filed 2020-04-03 | $42.97M 10-Q · filed 2020-04-03 | $65.52M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-11-30 | $16.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | $32.58M 10-Q · filed 2019-12-27 | $55.14M derived: sum of 3 quarters · filed 2020-07-30 | $74.31M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-08-31 | $16.08M 10-Q · filed 2019-09-26 | $38.64M derived: sum of 2 quarters · filed 2020-07-30 | $57.81M derived: sum of 3 quarters · filed 2020-07-30 | $66.54M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-05-31 | $22.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $41.72M derived: sum of 2 quarters · filed 2020-07-30 | $50.46M derived: sum of 3 quarters · filed 2020-07-30 | $69.13M 10-K · filed 2020-07-30 | ||
| 2018-02-28 | $19.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | $27.91M derived: sum of 2 quarters · filed 2019-03-29 | $46.58M 10-Q · filed 2019-03-29 | |||
| 2017-11-30 | $8.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | $27.41M 10-Q · filed 2018-12-28 | ||||
| 2017-08-31 | $18.67M 10-Q · filed 2018-10-05 | |||||
| 2017-05-31 | $60.27M 10-K · filed 2019-07-30 | |||||
| 2016-05-31 | $35.33M 10-K · filed 2018-07-27 | |||||
| 2014-05-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $10.94M derived: sum of 2 quarters · filed 2014-07-30 | $16.16M derived: sum of 3 quarters · filed 2014-07-30 | $21.67M 10-K · filed 2014-07-30 | ||
| 2014-02-28 | $6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $11.65M derived: sum of 2 quarters · filed 2014-04-04 | $17.16M 10-Q · filed 2014-04-04 | $23.84M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2013-11-30 | $5.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $10.73M 10-Q · filed 2014-01-09 | $17.40M derived: sum of 3 quarters · filed 2014-07-30 | $25.96M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2013-08-31 | $5.51M 10-Q · filed 2013-09-30 | $12.18M derived: sum of 2 quarters · filed 2014-07-30 | $20.73M derived: sum of 3 quarters · filed 2014-07-30 | $27.63M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2013-05-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $15.23M derived: sum of 2 quarters · filed 2014-07-30 | $22.12M derived: sum of 3 quarters · filed 2014-07-30 | $26.56M 10-K · filed 2014-07-30 | ||
| 2013-02-28 | $8.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $15.44M derived: sum of 2 quarters · filed 2014-04-04 | $19.89M 10-Q · filed 2014-04-04 | $19.72M 10-Q · filed 2013-03-28 | $28.93M derived: sum of 4 quarters · filed 2014-07-30 | |
| 2012-11-30 | $6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $11.33M 10-Q · filed 2014-01-09 | $20.38M derived: sum of 3 quarters · filed 2014-07-30 | $27.44M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-08-31 | $4.44M 10-Q · filed 2013-09-30 | $13.49M derived: sum of 2 quarters · filed 2014-07-30 | $20.55M derived: sum of 3 quarters · filed 2014-07-30 | $25.37M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-05-31 | $9.04M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $16.10M derived: sum of 2 quarters · filed 2014-07-30 | $20.93M derived: sum of 3 quarters · filed 2014-07-30 | $22.28M 10-K · filed 2014-07-30 | ||
| 2012-02-29 | $7.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $11.89M derived: sum of 2 quarters · filed 2013-03-28 | $13.23M 10-Q · filed 2013-03-28 | $18.12M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-11-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $6.17M 10-Q · filed 2012-12-28 | $11.06M derived: sum of 3 quarters · filed 2013-07-30 | $15.46M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-08-31 | $1.35M 10-Q · filed 2012-09-28 | $6.23M derived: sum of 2 quarters · filed 2013-07-30 | $10.63M derived: sum of 3 quarters · filed 2013-07-30 | $18.64M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-05-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $9.28M derived: sum of 2 quarters · filed 2013-07-30 | $17.30M derived: sum of 3 quarters · filed 2013-07-30 | $28.84M 10-K · filed 2013-07-30 | ||
| 2011-02-28 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $12.41M derived: sum of 2 quarters · filed 2012-03-30 | $23.96M 10-Q · filed 2012-03-30 | |||
| 2010-11-30 | $8.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $19.56M 10-Q · filed 2011-12-30 | ||||
| 2010-08-31 | $11.55M 10-Q · filed 2011-09-30 | |||||
| 2010-05-31 | $27.99M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |